<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11384525</article-id><article-id pub-id-type="pmc">2631792</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Threlfall</surname><given-names>E. J.</given-names></name><email>jthrelfall@phls.nhs.uk</email></contrib><contrib contrib-type="author"><name><surname>Ward</surname><given-names>L. R.</given-names></name></contrib></contrib-group><aff>Central Public Health Laboratory, London, United Kingdom.</aff><pub-date pub-type="ppub"><season>May-Jun</season><year>2001</year></pub-date><volume>7</volume><issue>3</issue><fpage>448</fpage><lpage>450</lpage><abstract><p>In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.</p></abstract></article-meta></front></article>